Semax for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Semax for Health & Longevity

Created on 10/01/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Semax, a short synthetic nasal peptide, is a prescription medicine in Russia, mainly for stroke recovery, and an unregulated focus aid elsewhere. Added to standard care, it was linked to better recovery after stroke and better vision in optic nerve and diabetic eye disease, in small studies that did not assign treatment at random. Benefits for healthy brains remain largely untested; reported side effects are mostly mild nasal irritation. (Full Review)

Protocol

Fatigue and stress label protocol (0.1%)
400–900 µg/day
2–3 drops per nostril, 2–3 times in the first half of the day, for 3–5 days; repeated as needed
Time of day
Morning or early afternoon
As specified by the label; stimulant-like effects may impair sleep if used late
Single versus split dosing
Split dosing
Each instillation capped at 2–3 drops per nostril; 10–15 minute gaps when higher doses are needed
Time to effect
Stroke recovery
Weeks
Recovery effects appeared over weeks of rehabilitation
Clinical outcomes
10–14 days
Russian clinical protocols assess outcomes after 10–14 day courses
Alertness
Minutes to hours
As described by users; functional effects last 20–24 hours

Benefits

Contraindications
  • Any history of seizures or epilepsy
  • Acute psychosis, mania or anxiety disorders
  • Pregnancy (any trimester) and breastfeeding
  • Children under 7 years; under 18 years for ophthalmic or neurosurgical use
  • Known hypersensitivity to Semax or methylparaben
  • Athletes subject to World Anti-Doping Agency (WADA) testing
  • Active cancer (theoretical; caution rather than absolute)
    •
Key Interactions
  • Psychostimulants (amphetamine): caution
  • Serotonergic antidepressants (sertraline) and monoamine oxidase inhibitors (phenelzine): monitor
  • Dopamine-blocking antipsychotics (haloperidol): caution
  • Seizure-threshold-lowering drugs (bupropion): caution
  • Glucose-lowering drugs (insulin): monitor
  • Anticoagulants and antiplatelets (warfarin): monitor
  • Over-the-counter nasal decongestants (oxymetazoline): caution
  • Over-the-counter stimulants (caffeine): monitor
  • Stimulant supplements and nootropics (racetams): monitor
  • Serotonergic supplements (St. John's wort): monitor
  • Supplements with additive antiplatelet effects (ginkgo): monitor
  • Supplements with additive BDNF-related effects (lion's mane) and Selank: monitor
  • Other interventions (alcohol, general anesthesia): monitor
    •

Risk & Side Effects

  • High:
  • Medium: Nasal irritation and mucosal discoloration; raised blood glucose in people with diabetes
    •
  • Low: Lowered seizure threshold
    •
  • Speculative: Anxiety, overstimulation or insomnia; unknown long-term growth-factor effects; immune reactions to injected preparations; increased bleeding tendency; unverified grey-market products
    •

Monitoring

Marker Target Why
Fasting glucose 75–90 mg/dL Detects reported glucose rise
HbA1c Below 5.4% Longer-term glucose control
Blood pressure Below 120/80 mmHg Detects stimulant-like effects
Resting heart rate 50–70 beats/min Detects overstimulation
Basic metabolic panel Within laboratory reference ranges General safety baseline
Plasma BDNF No established target; track change from own baseline Research marker of target engagement
Computerized cognitive battery score No established target; track change from own baseline Measures the intended benefit

Cadence: Baseline before a first course; during the first course, blood pressure, heart rate and sleep daily and fasting glucose weekly (with diabetes or prediabetes); cognitive battery after each course; laboratory tests every 6–12 months with repeated courses

Qualitative Assessment

  • Sustained attention and mental stamina during demanding work
  • Working memory and word-finding ease
  • Sleep onset time and sleep quality
  • Mood, irritability and anxiety level
  • Nasal comfort (irritation, discoloration, nosebleeds)
  • Headache frequency
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.